An MHRA consultation is due to end on 31 August, with public comments on AQbD principles closing soon.
List view / Grid view
Filter the results
This series investigates the growing interest from the pharmaceutical industry in cannabinoids. In this first piece, we hear from industry experts about the current situation of the ingredient on the pharmaceutical market.
An open letter has underscored the challenges of return failure in the US drug supply chain, especially after the introduction of the Drug Supply Chain Security Act in November.
Get QC Results for Advanced Therapy Medicinal Products (ATMPs) Before Treatment.
7 August 2019 | By WITec GmbH
This webinar will describe how Raman microscopy can help solve some of the most vital and challenging questions that researchers face in 3D imaging and microparticle analyses of food, pharmaceuticals and microplastics, along with providing measurement examples from each field.
Regulations provide specifications for the selection of an effective air monitoring strategy, both directly and indirectly.
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.
Tecan Partnering has consolidated its extensive OEM system development services for life sciences and IVD instruments to create Tecan Synergence™.
The pharmaceutical industry is set to face some major changes in the near future, to improve the quality of returned drugs and medications.
Two lots of Kogenate® FS vials actually contain the FVIII hemophilia A treatment, Jivi®.